Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Smoking Cessation and Mood Management for ACS Patients (PACES Phase IV Vanguard R56 Trial)

NCT03029923 is registered in ClinicalTrials.gov with The Miriam Hospital as lead sponsor.

NCT NCT03029923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03029923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Smoking Cessation and Mood Management for ACS Patients (PACES Phase IV Vanguard R56 Trial)
Lead sponsor
The Miriam Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
February 1, 2017
Completion date
December 1, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, tobacco use